Skip to main content

Table 5 mcfDNA assay with positive impact, reason for positive impact

From: Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study

Reason for positive Impact

N (%)

Led to new diagnosis

6 (17.6)

Led to confirmation of diagnosis

11 (32.4)

Led to earlier diagnosis

2 (5.9)

Avoided invasive procedure

3 (8.8)

Led to appropriate antimicrobials

6 (17.6)

Led to de-escalation of antimicrobials

16 (47.1)